Tyrosine Kinase/Adaptors
Tyrosine kinase and adaptor inhibitors are compounds that target tyrosine kinases and their associated adaptor proteins, which play pivotal roles in cell signaling, growth, and differentiation. These inhibitors are essential tools in cancer research, as many tyrosine kinases are involved in the signaling pathways that drive tumor growth and metastasis. By inhibiting tyrosine kinases, these compounds can block critical signaling cascades, offering potential therapeutic strategies for various cancers and other diseases involving abnormal cell signaling. At CymitQuimica, we provide a comprehensive range of high-quality tyrosine kinase and adaptor inhibitors to support your research in oncology, molecular biology, and targeted therapy development.
Read more
Subcategories of "Tyrosine Kinase/Adaptors"
ALK
CSF-1R
EGFR
Ephrin Receptor
FLT
Fibroblast Growth Factor Receptor (FGFR)
HER
Hck
IGF-1R
PDGFR
PYK2
Src
TAM Receptor
Tie-2
Trk receptor
Tyrosine Kinases
VEGFR
c-Fms
c-Kit
c-Met/HGFR
c-RET
Show 13 more subcategories
Products of "Tyrosine Kinase/Adaptors"
TAS05567
CAS:1429038-15-2
TAS05567 is a potent, highly selective, and ATP-competitive Syk inhibitor (IC50: 0.37 nM).
Formula:
C21H29N9O2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
439.51
Ref: TM-T16995
| 25mg | 2,106.00 € | ||
| 50mg | 2,785.00 € | ||
| 100mg | 3,739.00 € |
Estimated delivery in United States, on Wednesday 5 Mar 2025
GENZ-882706
CAS:2070864-35-4
GENZ-882706 is a potent colony stimulating factor-1 receptor (CSF-1R) Inhibitor.
Formula:
C26H25N5O3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
455.51
Ref: TM-T11390
| 25mg | 1,976.00 € | ||
| 50mg | 2,588.00 € | ||
| 100mg | 4,152.00 € |
Estimated delivery in United States, on Wednesday 5 Mar 2025
(-)-Cevimeline hydrochloride hemihydrate
(-)-Cevimeline HCl hemihydrate, a muscarinic agonist, treats Sjogren's xerostomia. Quick absorption, species-dependent metabolism.
Formula:
C10H19ClNO1·5S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
244.78
Ref: TM-T13421
| 25mg | 3,673.00 € |
Estimated delivery in United States, on Wednesday 5 Mar 2025
Protopine hydrochloride
CAS:6164-47-2
Protopine inhibits thromboxane, lowers intracellular calcium, and reduces cell adhesion by altering adhesive factors.
Formula:
C20H20ClNO5
Purity:
98%
Color and Shape:
Prisms From Alc Solid
Molecular weight:
389.83
Ref: TM-TMA1944
| 1mg | 394.00 € | ||
| 500µg | 221.00 € |
Estimated delivery in United States, on Wednesday 5 Mar 2025
NMS-P626
CAS:942471-37-6
NMS-P626 functions as an inhibitor targeting TRKA, TRKB, and TRKC, exhibiting IC 50 values of …
Formula:
C28H35F2N7O4S
Color and Shape:
Liquid
Molecular weight:
603.68
Ref: TM-T200149
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Wednesday 5 Mar 2025
AMG-25
CAS:1003311-62-3
AMG-25 (c-Kit-IN-5-1) is a c-Kit inhibitor that inhibits c-Kit, KDR, p38, Lck, and Src, and …
Formula:
C23H17N5O2
Purity:
98.16%
Color and Shape:
Solid
Molecular weight:
395.41
Ref: TM-T22256
| 2mg | 466.00 € |
Estimated delivery in United States, on Wednesday 5 Mar 2025
KRC-00715
CAS:2079853-72-6
KRC-00715 is an orally effective inhibitor of c-Met, exhibiting high selectivity with an IC50 of …
Formula:
C25H25F3N8O3
Color and Shape:
Liquid
Molecular weight:
542.51
Ref: TM-T200380
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Wednesday 5 Mar 2025
AZ8010
CAS:1035270-44-0
AZ8010 (AZ12908010) serves as an effective inhibitor of FGFR1-3 and exhibits antiproliferative properties, making it …
Formula:
C27H34N4O3
Color and Shape:
Liquid
Molecular weight:
462.58
Ref: TM-T89951
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Wednesday 5 Mar 2025
PF-06273340
CAS:1402438-74-7
PF-06273340: selective pan-Trk inhibitor (IC50: Trk-A 6 nM, B 4 nM, C 3 nM), low …
Formula:
C23H22ClN7O3
Purity:
98% - 98.00%
Color and Shape:
Solid
Molecular weight:
479.92
Ref: TM-T19649
| 1mg | 170.00 € |
Estimated delivery in United States, on Wednesday 5 Mar 2025
Tarloxotinib bromide
CAS:1636180-98-7
Tarloxotinib bromide (TH-4000) is an irreversible inhibitor of EGFR/HER2.
Formula:
C24H24Br2ClN9O3
Purity:
97.15%
Color and Shape:
Solid
Molecular weight:
681.77
Ref: TM-T13088
| 1mg | 136.00 € | ||
| 5mg | 272.00 € | ||
| 10mg | 416.00 € | ||
| 25mg | 681.00 € | ||
| 50mg | 902.00 € | ||
| 100mg | 1,261.00 € | ||
| 1mL*10mM (DMSO) | 420.00 € |
Estimated delivery in United States, on Wednesday 5 Mar 2025
Neptinib
CAS:2085843-51-0
Neptinib (NEP010), a derivative of Afatinib, exhibits enhanced antitumor properties and improved pharmacokinetics when administered …
Formula:
C22H23ClFN5O2
Color and Shape:
Liquid
Molecular weight:
443.9
Ref: TM-T89923
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Wednesday 5 Mar 2025
c-Met-IN-2
CAS:1635406-73-3
c-Met-IN-2 is a selective and orally available c-Met inhibitor (IC50: 0.6 nM) with antitumor activity.
Formula:
C24H21FN10O
Purity:
98%
Color and Shape:
Solid
Molecular weight:
484.49
Ref: TM-T10654
| 25mg | 2,106.00 € | ||
| 50mg | 2,785.00 € | ||
| 100mg | 3,739.00 € |
Estimated delivery in United States, on Wednesday 5 Mar 2025
ROS1-IN-2
CAS:2120337-16-6
ROS1-IN-2 (Compound 3), a ROS1 inhibitor, is utilized in cancer research.
Formula:
C29H37ClN5O2P
Color and Shape:
Liquid
Molecular weight:
554.06
Ref: TM-T89912
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Wednesday 5 Mar 2025
SYHA1815
CAS:2760195-67-1
SYHA1815, an orally active RET inhibitor (IC50=0.9 nmol/L), demonstrates antitumor activity. It exhibits greater selectivity …
Formula:
C27H26ClF4N5O
Color and Shape:
Liquid
Molecular weight:
547.98
Ref: TM-T200124
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Wednesday 5 Mar 2025
HS-345
CAS:1462329-41-4
HS-345, a TrkA/Akt inhibitor, exhibits potent anti-pancreatic cancer properties. This compound inhibits the growth and …
Formula:
C19H18N6O2S
Color and Shape:
Liquid
Molecular weight:
394.45
Ref: TM-T200230
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Wednesday 5 Mar 2025
BPI-15086
CAS:1644502-33-9
BPI-15086 is an orally active, effective, irreversible inhibitor selective for mutations, targeting both EGFR and …
Formula:
C29H33ClN8O4
Color and Shape:
Liquid
Molecular weight:
593.08
Ref: TM-T200004
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Wednesday 5 Mar 2025
AZD-5672
CAS:780750-65-4
AZD-5672 is an antagonist of CCR5 with an IC50 of 0.32 nM.
Formula:
C32H38F2N2O5S2
Purity:
95.58%
Color and Shape:
Solid
Molecular weight:
632.78
Ref: TM-T30260
| 1mg | 198.00 € | ||
| 5mg | 449.00 € | ||
| 10mg | 628.00 € | ||
| 25mg | 916.00 € | ||
| 50mg | 1,281.00 € | ||
| 100mg | 1,744.00 € | ||
| 1mL*10mM (DMSO) | 547.00 € |
Estimated delivery in United States, on Wednesday 5 Mar 2025
EGFR-IN-122
CAS:1807453-44-6
EGFR-IN-122 (compound Yfq07) serves as a potent inhibitor of EGFR. It effectively inhibits the proliferation …
Formula:
C19H20N4O3
Color and Shape:
Liquid
Molecular weight:
352.39
Ref: TM-T200157
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Wednesday 5 Mar 2025
ES-072
CAS:2089721-94-6
ES-072, a selective inhibitor targeting the EGFR mutant (EGFR-T790M), is administered orally. By hindering EGFR-T790M …
Formula:
C25H27F3N8O2
Color and Shape:
Liquid
Molecular weight:
528.53
Ref: TM-T200087
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Wednesday 5 Mar 2025
ONO-7579
CAS:1622212-25-2
ONO-7579, an orally active TRKA inhibitor, effectively suppresses tumor growth by inhibiting TRKA phosphorylation. In …
Formula:
C24H18ClF3N6O4S
Color and Shape:
Liquid
Molecular weight:
578.95
Ref: TM-T200301
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Wednesday 5 Mar 2025
